Xenon Pharmaceuticals (XENE) EBIT Margin Growth (1y) (2014 - 2022)
Xenon Pharmaceuticals (XENE) EBIT Margin Growth (1y) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -10,520.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.87 Mn |
| Jun 30, 2022 | -464,145.00 |
| Mar 31, 2022 | 17,035.00 |
| Dec 31, 2021 | -41,372.00 |
| Sep 30, 2021 | -4,401.00 |
| Jun 30, 2021 | -100,951.00 |
| Mar 31, 2021 | -25,500.00 |
| Dec 31, 2020 | 9,746.00 |
| Sep 30, 2020 | 10,776.00 |
| Dec 31, 2017 | -4.89 Mn |
| Sep 30, 2017 | -149,918.00 |
| Jun 30, 2017 | -5.11 Mn |
| Mar 31, 2017 | -4.90 Mn |
| Dec 31, 2016 | -137,200.00 |
| Sep 30, 2016 | -175,596.00 |
| Jun 30, 2016 | -154,632.00 |
| Mar 31, 2016 | -78,839.00 |
| Dec 31, 2015 | -8,138.00 |
| Sep 30, 2015 | -8,474.00 |
| Jun 30, 2015 | -2,109.00 |